Olivier Le Tilly

4PUBLICATIONS
9CO-AUTHORS
Molecular medicineMolecular targetsClimate change impacts and adaptation not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 19, 2024
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.

Olivier Le Tilly, Philippe Gatault, Saida Semlali

|Jan 19, 2022
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model.

Olivier Le Tilly, Philippe Gatault, Christophe Baron

|Mar 30, 2019
Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link?

Bérenger Largeau, Olivier Le Tilly, Bénédicte Sautenet

Pageof 1